TARRYTOWN, N.Y.--(BUSINESS WIRE)--Nov. 7, 2005--Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) today announced its results of operations for the three months ended September 30, 2005 and first nine months of 2005.
TARRYTOWN, N.Y.--(BUSINESS WIRE)--Nov. 7, 2005--Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) today announced its results of operations for the three months ended September 30, 2005 and first nine months of 2005.